NEXTCURE INC. - COMMO
1.3800
08-October-24 14:59:57
15 minutes delayed
Stocks
+0.0300
+2.22%
Today's range
1.3573 - 1.4100
ISIN
N/A
Source
NASDAQ
-
07 Sep 2023 15:05:00 By Nasdaq GlobeNewswire
-
Preclinical Data Demonstrate Potential Application of Anti-Siglec-15 Treatment in Bone Disease
05 Sep 2023 15:05:00 By Nasdaq GlobeNewswire
-
NextCure to Present at the H.C. Wainwright 25th Annual Global Investment Conference
31 Aug 2023 06:00:00 By Nasdaq GlobeNewswire
-
NextCure Provides Business Update and Reports Second Quarter 2023 Financial Results
03 Aug 2023 15:05:01 By Nasdaq GlobeNewswire
-
21 Jun 2023 15:05:00 By Nasdaq GlobeNewswire
-
NextCure to Present at the JMP Securities Life Sciences Conference
09 May 2023 06:00:01 By Nasdaq GlobeNewswire
-
NextCure Provides Business Update and Reports First Quarter 2023 Financial Results
04 May 2023 15:05:02 By Nasdaq GlobeNewswire
-
NextCure to Present at 22nd Annual Needham Virtual Healthcare Conference
11 Apr 2023 06:00:00 By Nasdaq GlobeNewswire
-
NextCure Provides Business Update and Reports Full Year 2022 Financial Results
02 Mar 2023 15:05:00 By Nasdaq GlobeNewswire
-
NextCure to Present at SVB Securities Global Biopharma Conference
07 Feb 2023 06:00:01 By Nasdaq GlobeNewswire
-
NextCure to Present at Upcoming Investor Conferences
22 Nov 2022 07:00:02 By Nasdaq GlobeNewswire
-
15 Nov 2022 15:30:00 By Nasdaq GlobeNewswire
-
07 Nov 2022 07:05:00 By Nasdaq GlobeNewswire
-
NextCure Provides Update and Reports Third Quarter 2022 Financial Results
03 Nov 2022 15:15:00 By Nasdaq GlobeNewswire
-
03 Nov 2022 08:15:00 By Nasdaq GlobeNewswire
-
NextCure Appoints Dr. Lisa M. Coussens to Scientific Advisory Board
27 Oct 2022 15:05:00 By Nasdaq GlobeNewswire
-
NextCure to Give Two Presentations at Society for Immunotherapy of Cancer Annual Meeting
05 Oct 2022 07:15:00 By Nasdaq GlobeNewswire
-
NextCure to Present at the Ladenburg Thalmann Healthcare Conference
22 Sep 2022 07:00:01 By Nasdaq GlobeNewswire